Scarica l'app Stockscreener
52.72
0.13%
-0.07
Dopo l'orario di chiusura:
52.73
0.010
+0.02%
Terns Pharmaceuticals Inc Borsa (TERN) Ultime notizie
Aug Mood: Can Terns Pharmaceuticals Inc be the next market leaderGap Up & Real-Time Stock Entry Alerts - baoquankhu1.vn
Barclays downgrades Terns Pharmaceuticals (TERN) - MSN
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
Terns Pharmaceuticals Grants Inducement Shares to New Employees - National Today
Merck nears deal to buy Terns Pharmaceuticals - MSN
Emil Kuriakose Sells 942 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat
Terns Pharmaceuticals (TERN) CMO sells shares to cover RSU taxes - Stock Titan
Press Release: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - Moomoo
Merck's $6.7 billion Terns Pharmaceuticals acquisition may face rival interest: Analyst - MSN
Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Merck nears $6 billion deal to buy Terns Pharma: Report - MSN
Merck Just Made a Big Bet on a New Cancer Growth Engine - Investing.com
Assessing Terns Pharmaceuticals (TERN) Valuation After Strong Recent Share Price Momentum - finance.yahoo.com
Terns Pharmaceuticals, Inc. $TERN Shares Purchased by JPMorgan Chase & Co. - MarketBeat
TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Merck & Co. (MRK) to acquire Terns Pharma for $6.7 billion - MSN
This Terns Pharmaceuticals analyst is no longer bullish; here are top 4 downgrades for Monday - MSN
Merck to buy Terns for $6.7 billion to grow in blood cancers - msn.com
Truist Securities downgrades Terns Pharmaceuticals (TERN) - MSN
Investors question premium in Merck's $6.7B deal for Terns Pharmaanalyst - MSN
Terns Pharma (TERN) Downgraded by Truist Securities with Lowered Price Target | TERN Stock News - GuruFocus
Terns Pharmaceuticals (NASDAQ:TERN) Earns "Hold" Rating from Truist Financial - MarketBeat
Terns Pharmaceuticals (NASDAQ:TERN) Issues Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Barclays Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Cuts Target Price to $53 - Moomoo
Terns Pharmaceuticals | 10-K: Annual report - Moomoo
SLS vs. TERN: Which pharma stock has more upside as Merck eyes $6B cancer bet ahead of Keytruda patent cliff - MSN
Merck to acquire Terns in $6.7 billion deal – signaling fresh push in competitive cancer drug race - MSN
Truist Financial Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Cuts Target Price to $53 - Moomoo
Terns Pharmaceuticals 10-K: $0 Revenue, $(1.03) EPS - TradingView
Terns Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Merck to buy Terns Pharmaceuticals (NASDAQ: TERN) for $53 per share in cash - Stock Titan
Barclays Downgrades Terns Pharma (TERN) Rating and Lowers Price Target | TERN Stock News - GuruFocus
Terns Pharmaceuticals (NASDAQ:TERN) Earns "Equal Weight" Rating from Barclays - MarketBeat
This Terns Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga
Terns Pharmaceuticals faces final earnings under acquisition cloud By Investing.com - Investing.com Canada
Terns Pharmaceuticals faces final earnings under acquisition cloud - Investing.com
Merck to Buy Terns Pharmaceuticals to Strengthen Drug Pipeline - Chemical Industry Digest
Barclays Downgrades Terns Pharmaceuticals to Equalweight From Overweight, Cuts Price Target to $53 From $56 - marketscreener.com
Barclays cuts Terns Pharmaceuticals stock rating on Merck deal By Investing.com - Investing.com Canada
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):